TGFB1 and neoplasm: Apatinib at low doses significantly alleviated tumor hypoxia, increased CD4+ and CD8+ cell infiltration, and decreased TGF-β levels at certain time points, suggesting that angiogenesis inhibitors have a true immunomodulatory effect37.